Engaging high and low burden countries in the "TB end game"

International Journal of Infectious Diseases

Volumn 45, Issue , 2016, Pages 100-102

  Marais, B J ^a   Outhred, A C ^a   Zumla, A ^b  

^a University of Sydney   (Australia)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Advocacy; Tuberculosis; World TB Day

Indexed keywords

STREPTOMYCIN;

DISEASE CONTROL; DRUG RESISTANT TUBERCULOSIS; EDITORIAL; HUMAN; MULTIDRUG RESISTANT TUBERCULOSIS; POVERTY; PROPHYLAXIS; TUBERCULOSIS; WORLD HEALTH ORGANIZATION; COST OF ILLNESS; ECONOMICS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

COST OF ILLNESS; HUMANS; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH ORGANIZATION;

EID: 84961795038     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2016.03.015     Document Type: Editorial

References (21)

1. Global Tuberculosis Report 2015. World Health Organisation, Geneva 2015.
2. Jenkins H.E., Tolman A.W., Yuen C.M., Parr J.B., Keshavjee S., Pérez-Vélez C.M., et al. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet 2014, 383:1572-1579.
3. Graham S., Sismandis C., Menzies H.J., Marais B.J., Detjen A.K., Black R.E. Importance of tuberculosis to address child survival. Lancet 2014, 383:1605-1607.
4. Raviglione M., Marais B., Floyd K., Lönnroth K., Getahun H., Migliori G.B., et al. Scaling up of interventions to achieve global tuberculosis control: progress, new developments and update. Lancet 2012, 379:1902-1913.
5. Abubakar I., Zignol M., Falzon D., Raviglione M., Ditiu L., Masham S., et al. Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis 2013, 13:529-539.
6. Kendall E.A., Fofana M.O., Dowdy D.W. L Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis. Lancet Respir Med 2015, 3:963-972.
7. Marais B.J., Mlambo C.K., Rastogi N., Zozzio T., Duse A., Victor T.C., et al. Epidemic spread of multidrug-resistant (MDR) tuberculosis in Johannesburg, South Africa. J Clin Microbiol 2013, 51:1818-1825.
8. Casali N., Nikolayevskyy V., Balabanova Y., Harris S.R., Ignatyeva O., Kontsevaya I., et al. Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat Genet 2014, 46:279-286.
9. Dobler C.C., Korver S., Batbayar O., Nyamdulam B., Oyuntsetseg S., Tsolmon B., et al. Multidrug-resistant tuberculosis among first-line treatment failures in Mongolia. Emerg Infect Dis 2015, 21:1451-1454.
10. Schaaf H.S., Marais B.J., Hesseling A.C., Brittle W., Donald P.R. Surveillance of antituberculosis drug resistance amongst children from the Western Cape Province of South Africa - an upward trend. Am J Public Health 2009, 99:1486-1490.
11. Jiao W.W., Liu Z.G., Han R., Zhao X.Q., Dong F., Dong H.Y., et al. Prevalence of drug resistant Mycobacterium tuberculosis among children in China. Tuberculosis 2015, 95(95):315-320.
12. Sanchez-Padilla E., Merker M., Beckert P., Jochims F., Dlamini T., Kahn P., et al. Detection of drug-resistant tuberculosis by Xpert MRB/RIF in Swaziland. N Engl J Med 2015, 372:1181-1182.
13. WHO 2014. End TB Strategy. - accessed February 24th 2016. http://www.who.int/tb/End_TB_brochure.pdf.
14. Marais B.J., Tadolini M., Zignol M., Migliori G.B. Paediatric TB - lessons from Denmark and inclusive strategies to consider. Eur Resp J 2014, 43:678-684.
15. Outhred A.C., Jelfs P., Suliman B., Hill-Cawthorne G.A., Crawford A.B., Marais B.J., et al. Added value of whole genome sequencing for management of highly drug resistant tuberculosis. J Antimicrob Chemother 2015, 70:1198-1202.
16. Outhred A.C., Holmes N., Sadsad R., Martinez E., Jelfs P., Hill-Cawthorne G.A., et al. Identifying Likely Transmission Pathways within a 10-Year Community Outbreak of Tuberculosis by High-Depth Whole Genome Sequencing. PLoS One 2016, 11(3):e0150550.
17. WHO 2014. Towards TB elimination: an action framework for low incidence countries. - accessed February 24th 2016. http://apps.who.int/iris/bitstream/10665/132231/1/9789241507707_eng.pdf.
18. Rangaka M.X., Cavalcante S.C., Marais B.J., Thim S., Martinson N.A., Swaminathan S., et al. Controlling the Seedbeds of Tuberculosis: Diagnosis and Treatment of Tuberculosis Infection. Lancet 2015, 386:2344-2353.
19. Hill P.C., Dye C., Viney K., Tabutoa K., Bissell K., Williams B.G., et al. Mass treatment to eliminate tuberculosis - a neglected strategy. Int J Tuberc Lung Dis 2014, 18:899-904.
20. Murray E., Bond V., Marais B.J., Godfrey-Faussett P., Ayles H., Beyers N. High levels of vulnerability and anticipated stigma reduce the impetus for tuberculosis diagnosis in Cape Town, South Africa. Health Policy Plan 2013, 28:410-418.
21. Islam T., Marais B.J., Nhung N.V., Chiang C.-Y., Yew W.W., Yoshiyama T., et al. Western Pacific Regional Green Light Committee: progress and way forward. Int J Infect Dis 2015, 32:161-165.